Paper Details

  1. Home
  2. Paper Details

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.

Author: KiharaJimmy H, KimaniBridget W, MbuguaAmos K, Ng'ang'aMurima, NjomoDoris W

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The recommended strategy for controlling schistosomiasis, a parasitic disease, is preventive chemotherapy with praziquantel. However, pre-school children (PSC) are often excluded from these programs. This study highlights the need to include PSC in treatment programs, especially in high-endemic areas where they are also at risk.
Paper Details　
Original Abstract of the Article :
The recommended strategy for control of schistosomiasis is preventive chemotherapy with praziquantel (PZQ). Pre-school children (PSC) are excluded from population treatment programs. In high endemic areas, these children are also at risk, and require treatment with PZQ. The Government of Kenya initi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205662/

データ提供：米国国立医学図書館（NLM）

Praziquantel: A Treatment Option for Schistosomiasis in Pre-School Children?

Schistosomiasis is a parasitic disease that continues to plague many parts of the world. This study examines the safety, efficacy, and acceptability of praziquantel (PZQ) in treating Schistosoma haematobium infection in pre-school children. PZQ is a widely used drug for schistosomiasis, but its use in pre-school children is a topic of debate. This research seeks to shed light on this important issue, hoping to find solutions to a problem that has plagued humanity for centuries.

Bridging the Gap: Treating Schistosomiasis in Pre-School Children

The study suggests that PZQ could be a safe and effective treatment for Schistosoma haematobium infection in pre-school children. However, the authors highlight the need for further research to fully assess the long-term effects of PZQ in this vulnerable population.

Protecting the Young: Addressing Schistosomiasis in Pre-School Children

This research provides valuable insights into the treatment of schistosomiasis in pre-school children. It emphasizes the importance of developing effective and safe treatment options for this age group, ultimately contributing to a healthier future for all.

Dr.Camel's Conclusion

This research explores the potential of PZQ as a treatment for schistosomiasis in pre-school children, a crucial step in combating this debilitating disease.

Date :
  1. Date Completed 2019-01-09
  2. Date Revised 2019-01-09
Further Info :

Pubmed ID

30332403

DOI: Digital Object Identifier

PMC6205662

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.